Prescient Healthcare Group

At Prescient, science is at the core of everything we do. We are a strategic product and portfolio partner that specializes in turning the science of biopharmaceuticals into value in healthcare. We help our clients develop winning strategies for their molecules every single day. By partnering with us, a molecule in your hands has greater potential for success than the same science in the hands of your competitors. Founded in 2007, Prescient is a partner with global reach and specialized capabilities, with six offices across three continents. Our team of more than 150 experts works with 22 of the top 25 biopharma companies, the fastest-growing mid-caps and cutting-edge emerging biotechs, including some of the biggest and most innovative brands. More than 80% of our employees hold advanced degrees and deliver impressive depth of therapeutic, clinical and commercial expertise, a wealth of relevant experience and knowledge of best practice and common pitfalls. Our average partnerships with product teams last more than five years and ~85% of business is generated through ongoing partnerships. Through aligned partnerships with shared goals that deliver accretive value on a daily basis, we adapt as your needs adapt. From molecule to product. From product to brand. From brand to the realization of your commercial goals. Our work is truly global, with about 65% of our engagements being focused on the mature markets of North America, Europe and Japan. The remaining 35% of work is concentrated on helping clients realize opportunities in the emerging markets of APAC, LATAM and EMEA. We support innovative products in oncology, hematology, immunology, respiratory disease, cardiology and metabolic disease, neurosciences and infectious diseases. And we are heavily involved in biosimilars, generics, vaccines and rare diseases. Prescient has been a portfolio company of Baird Capital since 2017.